Safety and Clinical Effects of Switching From Intravenous to Oral Nimodipine Administration in Aneurysmal Subarachnoid Hemorrhage
Objective: Several guidelines recommend oral administration of nimodipine as vasospasm prophylaxis after aneurysmal subarachnoid hemorrhage (SAH). However, in clinical practice, the drug is administered orally and intravenously (i.v.), depending on clinical conditions and local treatment regimens. W...
Guardado en:
Autores principales: | Jennifer Göttsche, Nils Schweingruber, Julian Christopher Groth, Christian Gerloff, Manfred Westphal, Patrick Czorlich |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a0abcd15fffd4500a8001d9515d1dcb9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Terapia continua intra-arterial selectiva con nimodipino para el tratamiento del vasoespasmo refractario en hemorragia subaracnoidea aneurismática. Caso clínico
por: Regueira,Tomás, et al.
Publicado: (2019) -
Effects of levosimendan on occurrence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a case–control study
por: Antoine Trinh-Duc, et al.
Publicado: (2021) -
Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Is There a Relevant Experimental Model? A Systematic Review of Preclinical Literature
por: Suzanne Goursaud, et al.
Publicado: (2021) -
Correlation of carbon dioxide and systolic velocity of the middle cerebral artery in patients with spontaneous subarachnoid hemorrhage of aneurysmal origin
por: Juan Esteban Muñoz Montoya, et al.
Publicado: (2022) -
Screening Computed Tomography Angiography to Identify Patients at Low Risk for Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage
por: Andrew M. Nguyen, et al.
Publicado: (2021)